Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation
PHASE2
This phase II trial studies how well olaparib works in treating patients wi...
Status
Active Not Recruiting
Location
UC Irvine Health/Chao Family Comprehensive Cancer Center
Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
PHASE2
This phase II MyeloMATCH treatment trial compares the effect of adding vene...
Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia
PHASE2
This phase II trial tests how well a ruxolitinib-based graft versus host di...
Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium